e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Molecular biology and tumoral markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic value of type I collagen cross-linked N-telopeptide in bone metastasis of lung cancer
M. Tekesin, G. Ozkan, E. Altunkaynak, N. D. Bakan, A. Gur, G. Camsari (Istanbul, Turkey)
Source:
Annual Congress 2004 - Molecular biology and tumoral markers
Session:
Molecular biology and tumoral markers
Session type:
Thematic Poster Session
Number:
595
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tekesin, G. Ozkan, E. Altunkaynak, N. D. Bakan, A. Gur, G. Camsari (Istanbul, Turkey). Diagnostic value of type I collagen cross-linked N-telopeptide in bone metastasis of lung cancer. Eur Respir J 2004; 24: Suppl. 48, 595
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002
Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Refractory remodelling of the microenvironment by type V collagen and apoptosis in non small cell lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Relation between bone metastasis in lung cancer and serum IL-6 levels
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Serum and EBC levels of cross-linked carboxy-terminal telopeptide of type I collagen in young patients with non-CF bronchiectases
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001
Clinical significance of serum osteopontin levels in lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Differential effects of collagen I and III and vitronectin on proliferation and apoptosis of human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 105s
Year: 2004
Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002
Bone mineral density is associated with the risk of non-small cell lung cancer, the HUNT study
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012
Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Detection of bone metastases in patients with NSCLC
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002
Tridimensional reconstruction and biochemical profile of collagen V alpha-2 chain in lung fibroblasts culture from patients with systemic sclerosis indicate a defect in fibrillogenesis microarchitecture
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Circulating fibrocytes and collagen turnover products in UIP: marker of disease activity and prognostic tool?
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007
The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept